Cargando…
Calcineurin Inhibitors and COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094752/ https://www.ncbi.nlm.nih.gov/pubmed/35568446 http://dx.doi.org/10.1016/j.reumae.2020.09.007 |
| _version_ | 1784705609499672576 |
|---|---|
| author | Hage, René Schuurmans, Macé M. |
| author_facet | Hage, René Schuurmans, Macé M. |
| author_sort | Hage, René |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9094752 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90947522022-05-12 Calcineurin Inhibitors and COVID-19 Hage, René Schuurmans, Macé M. Reumatol Clin (Engl Ed) Letter to the Editor Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. 2022-05 2022-05-11 /pmc/articles/PMC9094752/ /pubmed/35568446 http://dx.doi.org/10.1016/j.reumae.2020.09.007 Text en © 2020 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Hage, René Schuurmans, Macé M. Calcineurin Inhibitors and COVID-19 |
| title | Calcineurin Inhibitors and COVID-19 |
| title_full | Calcineurin Inhibitors and COVID-19 |
| title_fullStr | Calcineurin Inhibitors and COVID-19 |
| title_full_unstemmed | Calcineurin Inhibitors and COVID-19 |
| title_short | Calcineurin Inhibitors and COVID-19 |
| title_sort | calcineurin inhibitors and covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094752/ https://www.ncbi.nlm.nih.gov/pubmed/35568446 http://dx.doi.org/10.1016/j.reumae.2020.09.007 |
| work_keys_str_mv | AT hagerene calcineurininhibitorsandcovid19 AT schuurmansmacem calcineurininhibitorsandcovid19 |